Collegium Pharmaceutical

Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent protected DETERx™ formulation platform.
Cumberland, US
184 (est)
Collegium Pharmaceutical was founded in 2002 and is headquartered in Cumberland, US

Key People at Collegium Pharmaceutical

Michael T. Heffernan

Michael T. Heffernan

Co - Founder, President & CEO
Michael Heffernan

Michael Heffernan

Co-Founder, President, CEO
Heow Tan

Heow Tan

Vice President of Technical Operations

Collegium Pharmaceutical Locations

Cumberland, US

Collegium Pharmaceutical Metrics

Collegium Pharmaceutical Summary

Market capitalization

$383 M

Closing share price

Collegium Pharmaceutical's current market capitalization is $383 M.

Collegium Pharmaceutical Market Value History

Collegium Pharmaceutical Company Life

You may also be interested in